Does Gluten Cause Leaky Gut? The Truth About Wheat, Sourdough, and Digestion

By Rachel Carbone MS, BCDNM, LMT

Navigating the world of holistic nutrition often involves confronting deeply ingrained wellness myths and complex biological mechanisms. For those of us who embrace whole foods, cultivate our own gardens, and find joy in the rhythmic process of baking our own sourdough or milling fresh grains, the question of how wheat impacts our foundational well-being is paramount. A recurrent topic in our educational consultations is intestinal permeability, commonly referred to in wellness circles as "leaky gut." The overarching question remains: does consuming whole food forms of gluten fundamentally damage the intestinal barrier?

The short answer is nuanced: yes, gluten-containing whole foods can increase intestinal permeability, but this occurs predominantly in individuals with celiac disease and specific susceptible non-celiac groups, rather than the general healthy population. In this article, we will unpack the physiological mechanisms, explore the realities of sourdough fermentation, dissect the myths surrounding ancient wheats, and identify the hidden components in wheat that may actually be responsible for digestive discomfort.

Part 1: The Physiology of Intestinal Permeability and Gluten

To understand the relationship between wheat and the gut barrier, we must first understand the architecture of the intestines. The intestinal lining is a single layer of epithelial cells joined by complex protein networks known as tight junctions. These junctions act as selective gateways, allowing nutrients to pass into the bloodstream while keeping larger, potentially problematic molecules and microbes out. When these junctions loosen inappropriately, it results in intestinal hyperpermeability.

The Celiac Disease Paradigm

The strongest and most undeniable link between gluten and increased intestinal permeability exists within the context of celiac disease. In this specific population, the consumption of whole food forms of gluten causes a reproducible and reversible increase in permeability. Human gluten challenge studies have demonstrated this consistently over decades. For instance, foundational research showed that a single dose of gluten transiently worsens intestinal permeability in individuals with treated celiac disease (Hamilton et al., 1982). Furthermore, when individuals with celiac disease adhere to a strict gluten-free diet, their intestinal permeability often normalizes, highlighting the direct causal relationship (Duerksen et al., 2005; Cardoso-Silva et al., 2019).

The mechanism behind this dysfunction is well-documented. Gliadin, a primary protein fraction of gluten, has been shown to bind to the epithelial chemokine receptor CXCR3. This binding triggers a MyD88-dependent signaling pathway that culminates in the release of a protein called zonulin (Lammers et al., 2008). Zonulin directly modulates tight junctions, leading to their disassembly and an subsequent increase in intestinal permeability (Lammers et al., 2008; Paterson et al., 2007). Reviews spanning decades of research consistently describe this tight-junction remodeling, actin reorganization, and altered junctional protein expression as the central feature of gluten-related barrier disruption in celiac disease (Cenni et al., 2023; Barbaro et al., 2020; Scricciolo et al., 2017). A recent 2025 analysis reaffirmed that in celiac disease, increased permeability is a central and replicated feature of pathophysiology (Damianos et al., 2025).

Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity (NCGS)

Outside of celiac disease, the evidence becomes considerably more complex and heterogeneous. In some individuals with diarrhea-predominant Irritable Bowel Syndrome (IBS-D), a gluten-containing diet has been shown to increase small-bowel permeability, particularly in those who carry the HLA-DQ2/8 genetic markers (Vázquez-Roque et al., 2013). This permeability change in IBS-D was correlated with increased myosin light chain phosphorylation and claudin-15 expression, linking the exposure directly to epithelial barrier regulation rather than overt mucosal injury (Wu et al., 2016). However, when looking at self-reported Non-Celiac Gluten Sensitivity (NCGS), the data shifts. One pivotal human study evaluating individuals with self-reported NCGS and IBS found that when dietary FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) were controlled, there was no specific effect of gluten on intestinal epithelial integrity (Ajamian et al., 2020). This suggests that for many individuals who feel better on a "gluten-free" diet, the relief may actually stem from the removal of other wheat components, rather than gluten itself.

The General Healthy Population

For healthy individuals eating ordinary whole-food wheat products, the evidence supporting gluten-induced hyperpermeability is weak. While non-celiac biopsies can show a smaller, transient release of zonulin and increased permeability after direct exposure to gliadin extracts in laboratory settings (Lerner & Benzvi, 2021), this does not directly translate to free-living humans eating intact, whole-food wheat. Much of the mechanistic literature relies on gliadin fragments, isolated cell lines, or animal models (Freire et al., 2019; Shimada et al., 2019; Feng et al., 2021). Therefore, making a blanket statement that ordinary whole-food gluten damages the gut barrier in healthy people is not currently supported by rigorous human evidence (Barbara et al., 2021).

Holistic Insight: The human literature supports a conditional reality. Gluten exposure increases permeability clearly in celiac disease and appears to do so in some susceptible IBS-D individuals, but evidence is highly mixed outside these specific groups. Whole-food wheat effects are often deeply intertwined with other bioactive components, our unique microbiota, and our individual genetics.

Part 2: The Sourdough Factor: Can Fermentation Protect the Barrier?

Many individuals who prioritize whole-food, low-glycemic dietary patterns find themselves drawn to traditional food preparation methods. Sourdough baking, with its reliance on wild yeast and long fermentation, is frequently celebrated for improving the digestibility of bread. But does sourdough fermentation actually reduce gluten-induced intestinal permeability? The scientific evidence provides a highly specific answer: yes, sourdough fermentation can reduce gluten-induced intestinal permeability, but only under strictly controlled long-fermentation and high-proteolysis conditions, not necessarily with standard commercial or casual home sourdough methods. The protection is primarily documented in celiac challenge studies utilizing specialized sourdough protocols that extensively hydrolyze immunogenic gluten peptides (Di Cagno et al., 2004; Di Cagno et al., 2010).

The Science of Gluten Degradation in Sourdough

The clearest human result demonstrating a protective effect comes from an acute challenge study in celiac patients. In this trial, 13 out of 17 participants exhibited a marked alteration in intestinal permeability after consuming standard baker’s yeast bread. However, they did not experience this permeability increase after consuming a specialized long-fermented sourdough bread (Di Cagno et al., 2004). It is crucial to note the parameters of this specialized bread: it utilized a 24-hour fermentation period, highly selected strains of lactobacilli, cytoplasmic extracts, and a flour mixture where wheat comprised only 30% of the total volume (Di Cagno et al., 2004).

A subsequent pilot study extended this concept, using selected lactobacilli combined with fungal proteases to degrade the gluten content to below 10 parts per million (ppm). Celiac participants in remission who consumed this highly degraded sourdough maintained normal intestinal permeability, hematology, and serology over a 60-day challenge period (Di Cagno et al., 2010). While promising, the researchers noted that such foods require extensive formal trials before being recommended for celiac management (Di Cagno et al., 2010).

The Reality of Routine Fermentation

For those utilizing partial or routine sourdough fermentation, the outcomes are different. Complete gluten degradation generally requires prolonged fermentation times, multiple bacterial strains, and added peptidase activity (Costantini et al., 2022; Rashmi et al., 2020; Calasso et al., 2018). Partial sourdough fermentation changes the peptide release profile, but it does not consistently lower the total concentration of immunogenic peptides to safe levels (Ogilvie et al., 2021). In fact, routine fermentation often leaves gluten levels well above strict gluten-free thresholds, sometimes measuring around 98 to 112 mg/kg even after 48 hours of fermentation (Rashmi et al., 2020). Interestingly, some laboratory models have shown that specialized sourdough systems can attenuate permeability and cell damage in Caco-2 monolayers after gluten exposure (Fu et al., 2023).

Furthermore, the broader literature confirms that sourdough improves overall protein digestibility, enhances peptide release, and generates gut-active metabolites, even in spelt-based breads (Rizzello et al., 2019; Cicchi et al., 2025; Cera et al., 2026). Sourdough can also reduce the bioactivity of amylase-trypsin inhibitors (ATIs) when the dough pH drops below 4.0, and it can lower FODMAP content by up to 90% (Huang et al., 2020; Graça et al., 2021; Laatikainen et al., 2017). This significant reduction in FODMAPs and ATIs likely explains why many individuals with non-celiac wheat sensitivities tolerate sourdough better than conventional yeast bread, even if the gluten content remains relatively high (Ribet et al., 2022). Yet, clinical trials in IBS and wheat-sensitive groups have shown that sourdough bread is not always uniformly tolerated better than yeast bread, demonstrating the deep individual variability in digestive responses (Laatikainen et al., 2017; Calasso et al., 2018).

Part 3: Ancient Wheats: Einkorn, Emmer, Spelt, and Khorasan

A common educational exploration in holistic wellness involves substituting modern bread wheat with ancient varieties. For those who enjoy preparing fresh-milled whole wheat tortillas or rustic baked goods, varieties like spelt, einkorn, emmer, and khorasan are incredibly popular. A pervasive myth suggests that these ancient wheats contain less gluten than modern common wheat, making them universally safer for the intestinal barrier. The scientific consensus, however, clearly states otherwise. Spelt, einkorn, emmer, and khorasan usually do not contain less gluten than common wheat. In fact, comparative studies consistently reveal that these ancient varieties often possess similar or even higher total gluten content than modern bread wheat (Brouns et al., 2022; Correa et al., 2024; Geisslitz et al., 2019; Jahn et al., 2025).

Quantity vs. Quality

A rigorous 2024 species comparison demonstrated similar total gluten across einkorn, emmer, spelt, and common wheat, with spelt actually showing significantly higher levels, directly contradicting the belief that ancient wheats are naturally low-gluten (Correa et al., 2024). A 2019 multi-location agronomic study corroborated this, finding that einkorn, emmer, and spelt exhibited higher gluten contents than common wheat across all tested locations (Geisslitz et al., 2019). A comprehensive 2022 review concluded that ancient wheats contain more protein, more gluten, and a greater abundance of celiac-disease-active epitopes compared to bread wheat, meaning no single wheat type can be deemed safer for those with true celiac disease (Brouns et al., 2022). Differences among these grains are primarily driven by ploidy level (their genetic structure), making it unlikely that ancient wheats provide improved tolerability for severe wheat-related disorders based on gluten quantity alone (Jahn et al., 2025).

Why does the confusion persist? Ancient wheats generally boast a higher total protein content, which is sometimes mistakenly interpreted by consumers as implying a lower, less problematic gluten fraction (Correa et al., 2024; Gazza et al., 2023; Biel et al., 2021). The critical distinction lies in gluten functionality and composition. Ancient wheats often contain gluten that is weaker or differently composed, frequently displaying lower glutenin levels or higher gliadin-to-glutenin ratios. This creates a more extensible dough and affects baking dynamics, but it does not equate to a lower immunogenic load (Correa et al., 2024; Geisslitz et al., 2019; Hadnađev et al., 2021; Huertas-García et al., 2023). While some specific lines of einkorn have shown potentially lower immunogenicity or reduced ATI content, this is highly variable and does not classify the grain as gluten-free (Gazza et al., 2023; Janovská et al., 2021; Geisslitz et al., 2020; Geisslitz & Scherf, 2021). Ultimately, while ancient grains offer exceptional nutritional characteristics and physicochemical properties for food applications, they do not offer a reliably lower gluten quantity (Deyalage et al., 2024; Deyalage et al., 2026).

Part 4: The Hidden Culprits: ATIs, FODMAPs, and WGA

If the evidence for ordinary whole-food gluten causing leaky gut in healthy individuals is weak, why do so many people experience profound digestive issues, bloating, and fatigue when consuming whole wheat? The answer likely lies in the non-gluten components of the grain. Wheat is a complex matrix containing fermentable carbohydrates, non-gluten proteins, and lectins that can trigger severe gastrointestinal distress in susceptible individuals (An et al., 2025; Brouns et al., 2019). These components are increasingly recognized by the scientific community as the true culprits driving symptoms in Non-Celiac Wheat Sensitivity (NCWS) and IBS (Catassi et al., 2023; Geisslitz et al., 2022).

Fructans (FODMAPs)

Wheat is one of the primary dietary sources of fructans, which belong to the FODMAP family (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols). Wheat flour contains approximately 0.7 to 2.9 grams of fructans per 100 grams (Catassi et al., 2023; Verbeke, 2018). Due to their molecular size, these carbohydrates are poorly absorbed in the small intestine. They are highly osmotically active, meaning they draw water into the intestinal lumen, and they are rapidly fermented by gut bacteria in the colon. This dual action leads to significant water retention, gas production, abdominal pain, bloating, and diarrhea (Mumolo et al., 2020; Verbeke, 2018). A randomized crossover trial found that gastrointestinal symptoms were significantly more severe following fructan consumption compared to gluten consumption in individuals with self-reported NCWS (Verbeke, 2018). These symptoms are driven by osmotic and fermentative mechanisms rather than immune pathways, classifying them as food intolerances.

Amylase-Trypsin Inhibitors (ATIs)

Amylase-trypsin inhibitors (ATIs) represent about 2% to 4% of total wheat protein. Unlike many proteins, ATIs are highly resistant to intestinal proteolytic degradation, allowing them to reach the lower digestive tract largely intact (Geisslitz et al., 2021; Verbeke, 2018). Once there, ATIs can activate the innate immune system by binding to Toll-like receptor 4 (TLR4) on macrophages, monocytes, and dendritic cells, subsequently triggering the release of pro-inflammatory cytokines (Catassi et al., 2023; Verbeke, 2018). In murine (mouse) models, ATI exposure has been shown to induce barrier dysfunction and worsen gluten-induced inflammation, even without causing overt mucosal damage (Caminero et al., 2019). The bioactivity of ATIs persists in processed staples like bread and pasta, and standard daily dietary concentrations are sufficient to increase low-level intestinal inflammation in animal models (Zevallos et al., 2017).

Furthermore, ATI enzyme inhibition can lead to incomplete starch digestion, allowing starch fragments to ferment in the colon, further exacerbating bloating (Geisslitz et al., 2022). Because wheat contains ATIs alongside gluten, human and animal studies often struggle to isolate the effects of gluten from the effects of ATIs (Vázquez-Roque et al., 2013; Fernandez et al., 2019).

Wheat Germ Agglutinin (WGA) and Other Factors

Wheat germ agglutinin (WGA) is a lectin that has demonstrated the ability to disrupt the epithelial barrier and mucus layer in vitro, stimulating pro-inflammatory cytokine release (DePunder & Pruimboom, 2013; Mumolo et al., 2020). Undigestible gliadin peptide aggregates can also independently disrupt epithelial barriers (Feng et al., 2021). Additionally, external factors such as glyphosate, a widely utilized agricultural herbicide, have been proposed as potential environmental triggers interfering with crop integrity, although direct human trial evidence confirming its specific role in NCWS remains lacking (Mumolo et al., 2020; An et al., 2025).

Conclusion

Approaching holistic wellness requires us to separate reductionist myths from complex physiological realities. The compilation of evidence confirms that whole food forms of gluten can cause intestinal hyperpermeability, but this effect is robustly validated primarily in individuals with celiac disease and specific susceptible non-celiac subgroups. The most defensible scientific stance is that gliadin-containing foods can impair barrier function under specific biological and genetic contexts. For the general population, the digestive distress so frequently associated with wheat is heavily confounded by fructans (FODMAPs), innate-immune activating ATIs, lectins, host genetics, and the individual gut microbiota.

When optimizing our dietary patterns, whether we are sourcing einkorn, utilizing a prized sourdough starter, or mapping out a low-glycemic, high-fiber whole food plan, it is vital to recognize that our bodies react to the entire food matrix, not just isolated proteins. A gluten-free diet eliminates all wheat components simultaneously, making it difficult to pinpoint the exact trigger without systematic evaluation. Through targeted educational support, careful ingredient sourcing, and understanding our unique bio-individuality, we can navigate these ancient grains and modern realities to foster true, foundational resilience.

References

Ajamian, M., Rosella, G., Newnham, E., Biesiekierski, J., Muir, J., & Gibson, P. (2020). Effect of Gluten Ingestion and Fodmap Restriction on Intestinal Epithelial Integrity in Patients with Irritable Bowel Syndrome and Self-reported Non-coeliac Gluten Sensitivity. Molecular nutrition & food research, 64, e1901275.

An, C., Yang, P. J., Pinto-Sanchez, M. I., Verdu, M. E. F., Lebwohl, M. M. B., Green, M. P. F. H., & Alaedini, P. A. (2025). Molecular Triggers of Non-Celiac Wheat Sensitivity: A Scoping Review and Analysis. The American journal of gastroenterology, 120, 1998 - 2008.

Barbara, G., Barbaro, M., Fuschi, D., Palombo, M., Falangone, F., Cremon, C., Marasco, G., & Stanghellini, V. (2021). Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Frontiers in Nutrition, 8.

Barbaro, M., Cremon, C., Wrona, D., Fuschi, D., Marasco, G., Stanghellini, V., & Barbara, G. (2020). Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders. Nutrients, 12.

Biel, W., Jaroszewska, A., Stankowski, S., Sobolewska, M., & Kępińska-Pacelik, J. (2021). Comparison of yield, chemical composition and farinograph properties of common and ancient wheat grains. European Food Research and Technology, 247, 1525 - 1538.

Brouns, F., Geisslitz, S., Guzmán, C., Ikeda, T., Arzani, A., Latella, G., Simsek, S., Colomba, M., Gregorini, A., Zevallos, V., Lullien-Pellerin, V., Jonkers, D., & Shewry, P. (2022). Do ancient wheats contain less gluten than modern bread wheat, in favour of better health?. Nutrition Bulletin, 47, 157 - 167.

Brouns, F., Van Rooy, G., Shewry, P., Rustgi, S., & Jonkers, D. (2019). Adverse Reactions to Wheat or Wheat Components. Comprehensive reviews in food science and food safety, 18(5), 1437-1452.

Calasso, M., Francavilla, R., Cristofori, F., De Angelis, M., & Gobbetti, M. (2018). New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study. Nutrients, 10.

Caminero, A., McCarville, J. L., Zevallos, V., Pigrau, M., Yu, X. B., Jury, J., Galipeau, H., Clarizio, A., Casqueiro, J., Murray, J., Collins, S., Alaedini, A., Bercik, P., Schuppan, D., & Verdú, E. (2019). Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins. Gastroenterology, 156(8), 2266-2280.

Cao, S., Pierson, J. T., Bond, A., Zhang, S., Gold, A., Zhang, H., Zamary, K. M., Moats, P., Teegarden, M., Peterson, D., Mo, X., Zhu, J., & Bruno, R. S. (2024). Intestinal-level anti-inflammatory bioactivities of whole wheat: Rationale, design, and methods of a randomized, controlled, crossover dietary trial in adults with prediabetes. Nutrition research, 131, 83-95.

Cardoso-Silva, D., Delbue, D., Itzlinger, A., Moerkens, R., Withoff, S., Branchi, F., & Schumann, M. (2019). Intestinal Barrier Function in Gluten-Related Disorders. Nutrients, 11.

Catassi, C., Catassi, G., & Naspi, L. (2023). Nonceliac gluten sensitivity. Current Opinion in Clinical Nutrition and Metabolic Care, 26, 490 - 494.

Cenni, S., Sesenna, V., Boiardi, G., Casertano, M., Russo, G., Reginelli, A., Esposito, S., & Strisciuglio, C. (2023). The Role of Gluten in Gastrointestinal Disorders: A Review. Nutrients, 15.

Cera, S., Ojanen, M., Santapakka, E., Laitinen, M., Song, S., Hur, S., Katina, K., Maina, N. H., & Coda, R. (2026). Oat sourdough fermentation enhanced β-glucan viscosity and extractability from wholegrain oat bread in an in vitro gastrointestinal model. Food Hydrocolloids.

Cicchi, C., Leri, M., Bucciantini, M., Galli, V., Guerrini, S., Jiménez-Ortas, Á., Ceacero-Heras, D., Martínez-Augustín, O., Pazzagli, L., & Luti, S. (2025). Sourdough Breads Made with Selected Lactobacillus Strains and Spelt Flour Contain Peptides That Positively Impact Intestinal Barrier. Foods, 14.

Correa, S., Lepagneul, J., Thomas, M., Mayaud, L., Hamant, O., Samson, M., & Charreyre, M. (2024). Unraveling gluten protein compositions of einkorn, emmer, and spelt grown in the Lyon region in France. Cereal Chemistry.

Costantini, A., Da Ros, A., Nikoloudaki, O., Montemurro, M., Di Cagno, R., Génot, B., Gobbetti, M., & Rizzello, C. G. (2022). How cereal flours, starters, enzymes, and process parameters affect the in vitro digestibility of sourdough bread. Food research international, 159, 111614.

Damianos, J. A., Bledsoe, A., Camilleri, M., & Murray, J. A. (2025). Coeliac disease and the intestinal barrier: mechanisms of disruption and strategies for restoration. Gut, 75, 826 - 838.

De-Faria, F. M., Bednarska, O., Ström, M., Söderholm, J., Walter, S., & Keita, Å. (2021). Colonic paracellular permeability and circulating zonulin-related proteins. Scandinavian Journal of Gastroenterology, 56, 424 -431.

De Punder, K., & Pruimboom, L. (2013). The Dietary Intake of Wheat and other Cereal Grains and Their Role in Inflammation. Nutrients, 5, 771 - 787.

Deyalage, S. T., House, J., Thandapilly, S., & Malalgoda, M. (2024). Nutritional Characteristics and Physicochemical Properties of Ancient Wheat Species for Food Applications. Food Bioscience.

Deyalage, S. T., Whitney, K., Simsek, S., & Malalgoda, M. (2026). Comparative Evaluation of Starch and Protein Characteristics in Ancient Wheat Species. Cereal Chemistry.

Di Cagno, R., Barbato, M., Di Camillo, C., Rizzello, C., De Angelis, M., Giuliani, G., De Vincenzi, M., Gobbetti, M., & Cucchiara, S. (2010). Gluten-free Sourdough Wheat Baked Goods Appear Safe for Young Celiac Patients: A Pilot Study. Journal of Pediatric Gastroenterology and Nutrition, 51, 777–783.

Di Cagno, R., De Angelis, M., Auricchio, S., Greco, L., Clarke, C. I., De Vincenzi, M., Giovannini, C., D’Archivio, M., Landolfo, F., Parrilli, G., Minervini, F., Arendt, E., & Gobbetti, M. (2004). Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients. Applied and Environmental Microbiology, 70, 1088 - 1096.

Duerksen, D. R., Wilhelm-Boyles, C., & Parry, D. (2005). Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet. Digestive Diseases and Sciences, 50, 785-790.

Feng, G., Han, K., Li, Y., Yang, Q., Feng, W., Wang, J., & Yang, X. (2021). Undigestible Gliadin Peptide Nanoparticles Penetrate Mucus and Reduce Mucus Production Driven by Intestinal Epithelial Cell Damage. Journal of agricultural and food chemistry.

Fernandez, A. C., McCarville, J. L., Zevallos, V., Pigrau, M., Xuechen, Y., Jury, J., Galipeau, H., Casqueiro, J., Murray, J., Collins, S., Alaedini, A., Bercik, P., Schuppan, D., & Verdú, E. F. (2019). LACTOBACILLI DEGRADE WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) TO AMELIORATE GUT DYSFUNCTION INDUCED BY IMMUNOGENIC WHEAT PROTEINS. Journal of the Canadian Association of Gastroenterology.

Freire, R., Ingano, L., Serena, G., Çetinbas, M., Anselmo, A., Sapone, A., Sadreyev, R., Fasano, A., & Senger, S. (2019). Human gut derived-organoids provide model to tudy gluten response and effects of microbiota- derived molecules in celiac disease. Scientific Reports, 9.

Fu, W., Chen, C., Liu, C., Tao, S., & Xue, W. (2023). Changes in wheat protein digestibility and allergenicity: Role of Pediococcus acidilactici XZ31 and yeast during dough fermentation. Food Science and Human Wellness.

Gazza, L., Hidalgo, A., & Brandolini, A. (2023). A high protein ancient wheat species: Einkorn. Journal of Cereal Science.

Geisslitz, S., Longin, C. F., Koehler, P., & Scherf, K. (2020). Comparative quantitative LC–MS/MS analysis of 13 amylase/trypsin inhibitors in ancient and modern Triticum species. Scientific Reports, 10.

Geisslitz, S., Longin, C. F., Scherf, K., & Koehler, P. (2019). Comparative Study on Gluten Protein Composition of Ancient (Einkorn, Emmer and Spelt) and Modern Wheat Species (Durum and Common Wheat). Foods, 8.

Geisslitz, S., & Scherf, K. (2021). The Holy Grail of Ancient Cereals. Springer, 269-301.

Geisslitz, S., Shewry, P., Brouns, F., America, A., Caio, G., Daly, M., D’amico, S., De Giorgio, R., Gilissen, L., Grausgruber, H., Huang, X., Jonkers, D., Keszthelyi, D., Larré, C., Masci, S., Mills, C., Møller, M. S., Sorrells, M., Svensson, B., . . . Weegels, P. (2021). Wheat ATIs: Characteristics and Role in Human Disease. Frontiers in Nutrition, 8.

Geisslitz, S., Weegels, P., Shewry, P., Zevallos, V., Masci, S., Sorrells, M., Gregorini, A., Colomba, M., Jonkers, D., Huang, X., De Giorgio, R., Caio, G., D’amico, S., Larré, C., & Brouns, F. (2022). Wheat amylase/trypsin inhibitors (ATIs): occurrence, function and health aspects. European Journal of Nutrition, 61, 2873 - 2880.

Graça, C., Lima, A., Raymundo, A., & Sousa, I. (2021). Sourdough Fermentation as a Tool to Improve the Nutritional and Health-Promoting Properties of Its Derived-Products. Fermentation.

Hadnađev, M., Tomić, J., Škrobot, D., & Dapčević-Hadnađev, T. (2021). Rheological behavior of emmer, spelt and khorasan flours. Journal of Food Processing and Preservation.

Hamilton, I., Cobden, I., Rothwell, J., & Axon, A. (1982). Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut, 23, 202 - 210.

Huang, X., Schuppan, D., Zevallos, V., & Loponen, J. (2020). Sourdough Fermentation Degrades Wheat Alpha-Amylase/Trypsin Inhibitor (ATI) and Reduces Pro-Inflammatory Activity. Foods, 9.

Huertas-García, A. B., Guzmán, C., Ibba, M., Rakszegi, M., Sillero, J. C., & Alvarez, J. B. (2023). Processing and Bread-Making Quality Profile of Spanish Spelt Wheat. Foods, 12.

Jahn, N., Konradl, U., Fleissner, K., Geisslitz, S., & Scherf, K. (2025). Protein composition in ancient wheats is determined by ploidy level. Journal of Cereal Science.

Janovská, D., Čepková, P. H., D’amico, S., Brandolini, A., & Grausgruber, H. (2021). Developing hulled wheat-based cereal products with enhanced nutritional properties: emmer, einkorn and spelt. Springer, 267-292.

Laatikainen, R., Koskenpato, J., Hongisto, S., Loponen, J., Poussa, T., Huang, X., Sontag-Strohm, T., Salmenkari, H., & Korpela, R. (2017). Pilot Study: Comparison of Sourdough Wheat Bread and Yeast-Fermented Wheat Bread in Individuals with Wheat Sensitivity and Irritable Bowel Syndrome. Nutrients, 9.

Lammers, K., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea‐donohue, T., Tamiz, A., Alkan, S., Netzel‐Arnett, S., Antalis, T., Vogel, S., & Fasano, A. (2008). Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology, 135(1), 194-204.e3.

Lerner, A., & Benzvi, C. (2021). “Let Food Be Thy Medicine”: Gluten and Potential Role in Neurodegeneration. Cells, 10.

Mumolo, M., Rettura, F., Melissari, S., Costa, F., Ricchiuti, A., Ceccarelli, L., De Bortoli, N., Marchi, S., & Bellini, M. (2020). Is Gluten the Only Culprit for Non-Celiac Gluten/Wheat Sensitivity?. Nutrients, 12.

Ogilvie, O. J., Gerrard, J., Roberts, S., Sutton, K., Larsen, N., & Domigan, L. (2021). A Case Study of the Response of Immunogenic Gluten Peptides to Sourdough Proteolysis. Nutrients, 13.

Paterson, B., Lammers, K., Arrieta, M. C., Fasano, A., & Meddings, J. (2007). The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology & Therapeutics, 26.

Rashmi, B. S., Gayathri, D., Vasudha, M., Prashantkumar, C., Swamy, C., Sunil, K., Somaraja, P. K., & Prakash, P. (2020). Gluten hydrolyzing activity of Bacillus spp isolated from sourdough. Microbial Cell Factories, 19.

Ribet, L., Dessalles, R., Lesens, C., Brusselaers, N., & Durand-Dubief, M. (2022). Nutritional benefits of sourdoughs: A systematic review. Advances in Nutrition, 14, 22 - 29.

Rizzello, C., Portincasa, P., Montemurro, M., Di Palo, D. M., Lorusso, M., De Angelis, M., Bonfrate, L., Génot, B., & Gobbetti, M. (2019). Sourdough Fermented Breads are More Digestible than Those Started with Baker’s Yeast Alone: An In Vivo Challenge Dissecting Distinct Gastrointestinal Responses. Nutrients, 11.

Scricciolo, A., Roncoroni, L., Lombardo, V., Ferretti, F., Doneda, L., & Elli, L. (2017). Vitamin D3 Versus Gliadin: A Battle to the Last Tight Junction. Digestive Diseases and Sciences, 63, 1-3.

Shimada, S., Tanigawa, T., Watanabe, T., Nakata, A., Sugimura, N., Itani, S., Higashimori, A., Nadatani, Y., Otani, K., Taira, K., Hosomi, S., Nagami, Y., Tanaka, F., Kamata, N., Yamagami, H., Shiba, M., & Fujiwara, Y. (2019). Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage. PLoS ONE, 14.

Valitutti, F., & Fasano, A. (2019). Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments. Digestive diseases and sciences, 64, 1748 - 1758.

Vázquez-Roque, M., Camilleri, M., Smyrk, T., Murray, J., Marietta, E., O’Neill, J., Carlson, P., Lamsam, J., Janzow, D., Eckert, D. J., Burton, D., & Zinsmeister, A. (2013). A Controlled Trial of Gluten-Free Diet in Patients with Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function. Gastroenterology, 144, 903 - 911.e3.

Verbeke, K. (2018). Nonceliac Gluten Sensitivity: What Is the Culprit?. Gastroenterology, 154(3), 471-473.

Wu, R., Vázquez-Roque, M., Carlson, P., Burton, D., Grover, M., Camilleri, M., & Turner, J. (2016). Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression. Laboratory investigation; a journal of technical methods and pathology, 97, 14 - 23.

Zevallos, V., Raker, V., Tenzer, S., Jimenez-Calvente, C., Ashfaq-Khan, M., Rüssel, N., Pickert, G., Schild, H., Steinbrink, K., & Schuppan, D. (2017). Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells. Gastroenterology, 152(5), 1100-1113.e12.